{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:03:26Z","timestamp":1791194606202,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofpsychiatricresearch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jpsychires.2015.04.023","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T16:22:22Z","timestamp":1431102142000},"page":"112-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Advanced glycation end products and schizophrenia: A systematic review"],"prefix":"10.1016","volume":"66-67","author":[{"given":"Youssef","family":"Kouidrat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Amad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Daniel","family":"Lalau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenole","family":"Loas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanari","family":"Itokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2015.04.023_bib1","doi-asserted-by":"crossref","first-page":"238485","DOI":"10.1155\/2014\/238485","article-title":"Role of methylglyoxal in Alzheimer's disease","volume":"2014","author":"Angeloni","year":"2014","journal-title":"BioMed Res Int"},{"issue":"6","key":"10.1016\/j.jpsychires.2015.04.023_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archgenpsychiatry.2010.62","article-title":"Enhanced carbonyl stress in a subpopulation of schizophrenia","volume":"67","author":"Arai","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.04.023_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1475-2891-13-91","article-title":"Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review","volume":"13","author":"Arroll","year":"2014","journal-title":"Nutr J"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.04.023_bib4","first-page":"11","article-title":"Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review","volume":"52","author":"Arsov","year":"2014","journal-title":"Clin Chem Lab Med CCLM FESCC"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.04.023_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2007.07.025","article-title":"Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications","volume":"196","author":"Basta","year":"2008","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.jpsychires.2015.04.023_bib6","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.2337\/dc12-2689","article-title":"Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products","volume":"36","author":"Beisswenger","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.04.023_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.bp.109.067512","article-title":"Twenty-five year mortality of a community cohort with schizophrenia","volume":"196","author":"Brown","year":"2010","journal-title":"Br J Psychiatry J Ment Sci"},{"issue":"5","key":"10.1016\/j.jpsychires.2015.04.023_bib8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.0000122852.22604.78","article-title":"Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited","volume":"24","author":"Ceriello","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jpsychires.2015.04.023_bib9","doi-asserted-by":"crossref","first-page":"403460","DOI":"10.1155\/2013\/403460","article-title":"Receptor for advanced glycation end products and its involvement in inflammatory diseases","volume":"2013","author":"Chuah","year":"2013","journal-title":"Int J Inflamm"},{"issue":"3","key":"10.1016\/j.jpsychires.2015.04.023_bib10","first-page":"237","article-title":"Oxidative stress in schizophrenia \u2013 focusing on the main markers","volume":"23","author":"Ciobica","year":"2011","journal-title":"Psychiatr Danub"},{"issue":"8","key":"10.1016\/j.jpsychires.2015.04.023_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/156652407783220714","article-title":"Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response","volume":"7","author":"Clynes","year":"2007","journal-title":"Curr Mol Med"},{"issue":"10","key":"10.1016\/j.jpsychires.2015.04.023_bib12","doi-asserted-by":"crossref","first-page":"19891","DOI":"10.3390\/ijms141019891","article-title":"Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond","volume":"14","author":"Daffu","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.04.023_bib13","first-page":"52","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"DE Hert","year":"2011","journal-title":"World Psychiatry Off J World Psychiatr Assoc WPA"},{"issue":"4","key":"10.1016\/j.jpsychires.2015.04.023_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/biof.1018","article-title":"An update on advanced glycation endproducts and atherosclerosis","volume":"38","author":"Del Turco","year":"2012","journal-title":"BioFactors Oxf Engl"},{"issue":"4","key":"10.1016\/j.jpsychires.2015.04.023_bib15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/ATVBAHA.113.302731","article-title":"Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease","volume":"34","author":"De Vos","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.04.023_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpsychires.2012.10.005","article-title":"The dietary pattern of patients with schizophrenia: a systematic review","volume":"47","author":"Dipasquale","year":"2013","journal-title":"J\u00a0Psychiatr Res"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.04.023_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2010.10.003","article-title":"Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with different psychiatric disorders","volume":"487","author":"Emanuele","year":"2011","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.jpsychires.2015.04.023_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/YCO.0000000000000054","article-title":"Oxidative stress and schizophrenia: recent breakthroughs from an old story","volume":"27","author":"Emiliani","year":"2014","journal-title":"Curr Opin Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2015.04.023_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/dom.12058","article-title":"Current therapeutic interventions in the glycation pathway: evidence from clinical studies","volume":"15","author":"Engelen","year":"2013","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.jpsychires.2015.04.023_bib20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jada.2004.05.214","article-title":"Advanced glycoxidation end products in commonly consumed foods","volume":"104","author":"Goldberg","year":"2004","journal-title":"J\u00a0Am Diet Assoc"},{"issue":"42","key":"10.1016\/j.jpsychires.2015.04.023_bib21","doi-asserted-by":"crossref","first-page":"16621","DOI":"10.1073\/pnas.0706778104","article-title":"Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence","volume":"104","author":"Gysin","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.jpsychires.2015.04.023_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.semcdb.2011.02.005","article-title":"Altered glyoxalase 1 expression in psychiatric disorders: cause or consequence?","volume":"22","author":"Hambsch","year":"2011","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.jpsychires.2015.04.023_bib23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","article-title":"Role of advanced glycation end products in cardiovascular disease","volume":"4","author":"Hegab","year":"2012","journal-title":"World J Cardiol"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.04.023_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1189\/jlb.1206751","article-title":"Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress","volume":"82","author":"Herold","year":"2007","journal-title":"J\u00a0Leukoc Biol"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.04.023_bib25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1042\/BST20140044","article-title":"Carbonyl stress in schizophrenia","volume":"42","author":"Itokawa","year":"2014","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"10.1016\/j.jpsychires.2015.04.023_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.trsl.2011.12.004","article-title":"Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy","volume":"159","author":"Jack","year":"2012","journal-title":"Transl Res"},{"issue":"9","key":"10.1016\/j.jpsychires.2015.04.023_bib27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1373\/clinchem.2010.145201","article-title":"Evaluation of nonenzymatic posttranslational modification-derived products as biomarkers of molecular aging of proteins","volume":"56","author":"Jaisson","year":"2010","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.jpsychires.2015.04.023_bib28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/CS20080494","article-title":"RAGE: a novel biological and genetic marker for vascular disease","volume":"116","author":"Kalea","year":"2009","journal-title":"Clin Sci"},{"issue":"6","key":"10.1016\/j.jpsychires.2015.04.023_bib29","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/schbul\/sbt234","article-title":"Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia","volume":"40","author":"Katsuta","year":"2014","journal-title":"Schizophr Bull"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.04.023_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2014.04.013","article-title":"Advanced glycation\/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults","volume":"235","author":"Kizer","year":"2014","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.jpsychires.2015.04.023_bib31","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jpsychires.2013.03.016","article-title":"Increased advanced glycation end-products (AGEs) assessed by skin autofluorescence in schizophrenia","volume":"47","author":"Kouidrat","year":"2013","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.jpsychires.2015.04.023_bib32","first-page":"791573","article-title":"Eating disorders in schizophrenia: implications for research and management","volume":"2014","author":"Kouidrat","year":"2014","journal-title":"Schizophr Res Treat"},{"issue":"12","key":"10.1016\/j.jpsychires.2015.04.023_bib33","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1089\/ars.2012.4858","article-title":"Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models","volume":"18","author":"Kulak","year":"2013","journal-title":"Antioxid Redox Signal"},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2015.04.023_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.02.018","article-title":"Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective","volume":"317","author":"Li","year":"2012","journal-title":"J\u00a0Neurol Sci"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.04.023_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.comppsych.2009.05.009","article-title":"Mortality in Kraepelinian schizophrenic patients: a prospective study with a median follow-up of 8.4 years","volume":"51","author":"Loas","year":"2010","journal-title":"Compr Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2015.04.023_bib36","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.ijcard.2013.05.013","article-title":"Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases","volume":"168","author":"Mahajan","year":"2013","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.jpsychires.2015.04.023_bib37","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.jpsychires.2015.04.023_bib38","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/schbul\/sbt129","article-title":"Clinical features of schizophrenia with enhanced carbonyl stress","volume":"40","author":"Miyashita","year":"2014","journal-title":"Schizophr Bull"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.04.023_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/pcn.12081","article-title":"Replication of enhanced carbonyl stress in a subpopulation of schizophrenia","volume":"68","author":"Miyashita","year":"2014","journal-title":"Psychiatry Clin Neurosci"},{"issue":"4","key":"10.1016\/j.jpsychires.2015.04.023_bib40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpsychires.2015.04.023_bib41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","article-title":"Role of advanced glycation end products in cellular signaling","volume":"2","author":"Ott","year":"2014","journal-title":"Redox Biol"},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2015.04.023_bib42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jneuroim.2006.12.011","article-title":"Autocrine S100B effects on astrocytes are mediated via RAGE","volume":"184","author":"Ponath","year":"2007","journal-title":"J\u00a0Neuroimmunol"},{"issue":"4","key":"10.1016\/j.jpsychires.2015.04.023_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/CRD.0b013e318244e57c","article-title":"Advanced glycation end products and diabetic cardiovascular disease","volume":"20","author":"Prasad","year":"2012","journal-title":"Cardiol Rev"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.04.023_bib44","first-page":"11","article-title":"Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality","volume":"23","author":"Prasad","year":"2014","journal-title":"Int J Angiol Off Publ Int Coll Angiol Inc"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.04.023_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1042\/BST20140008","article-title":"Activity, regulation, copy number and function in the glyoxalase system","volume":"42","author":"Rabbani","year":"2014","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.04.023_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11897-012-0089-5","article-title":"Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure","volume":"9","author":"Ramasamy","year":"2012","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jpsychires.2015.04.023_bib47","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2147\/NDT.S52585","article-title":"Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia","volume":"9","author":"Saruwatari","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"7510","key":"10.1016\/j.jpsychires.2015.04.023_bib48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.04.023_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.jpsychires.2015.04.023_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pnpbp.2012.09.016","article-title":"Immune system and glucose metabolism interaction in schizophrenia: a chicken-egg dilemma","volume":"48","author":"Steiner","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.jpsychires.2015.04.023_bib51","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.biopsych.2008.10.044","article-title":"A\u00a0new pathophysiological aspect of S100B in schizophrenia: potential regulation of S100B by its scavenger soluble RAGE","volume":"65","author":"Steiner","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.04.023_bib52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.molmet.2013.11.006","article-title":"Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms","volume":"3","author":"Stirban","year":"2014","journal-title":"Mol Metab"},{"issue":"5","key":"10.1016\/j.jpsychires.2015.04.023_bib53","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.freeradbiomed.2011.05.004","article-title":"Reactive oxygen species in cardiovascular disease","volume":"51","author":"Sugamura","year":"2011","journal-title":"Free Radic Biol Med"},{"issue":"2\u20133","key":"10.1016\/j.jpsychires.2015.04.023_bib54","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.schres.2013.08.029","article-title":"Postmortem analysis of cardiovascular deaths in schizophrenia: a 10-year review","volume":"150","author":"Sweeting","year":"2013","journal-title":"Schizophr Res"},{"issue":"6","key":"10.1016\/j.jpsychires.2015.04.023_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jada.2010.03.018","article-title":"Advanced glycation end products in foods and a practical guide to their reduction in the diet","volume":"110","author":"Uribarri","year":"2010","journal-title":"J\u00a0Am Diet Assoc"},{"issue":"3","key":"10.1016\/j.jpsychires.2015.04.023_bib56","first-page":"240","article-title":"A\u00a0meta-analysis of cardio-metabolic abnormalities in drug na\u00efve, first-episode and multi-episode patients with schizophrenia versus general population controls","volume":"12","author":"Vancampfort","year":"2013","journal-title":"World Psychiatry Off J World Psychiatr Assoc WPA"},{"issue":"9690","key":"10.1016\/j.jpsychires.2015.04.023_bib57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia","volume":"374","author":"Van Os","year":"2009","journal-title":"Lancet"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jpsychires.2015.04.023_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/10715762.2013.815348","article-title":"Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation","volume":"47","author":"Vistoli","year":"2013","journal-title":"Free Radic Res"},{"issue":"12","key":"10.1016\/j.jpsychires.2015.04.023_bib59","doi-asserted-by":"crossref","first-page":"e50790","DOI":"10.1371\/journal.pone.0050790","article-title":"Meta-analysis of RAGE gene polymorphism and coronary heart disease risk","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2015.04.023_bib60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2013.02.015","article-title":"Free radicals, antioxidant defense systems, and schizophrenia","volume":"46","author":"Wu","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2015.04.023_bib61","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbagen.2011.03.014","article-title":"Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes","volume":"1820","author":"Yamagishi","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2015.04.023_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2006\/248387","article-title":"Altered glutathione redox state in schizophrenia","volume":"22","author":"Yao","year":"2006","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.04.023_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(98)00030-9","article-title":"Reduced status of plasma total antioxidant capacity in schizophrenia","volume":"32","author":"Yao","year":"1998","journal-title":"Schizophr Res"},{"issue":"3","key":"10.1016\/j.jpsychires.2015.04.023_bib64","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3956(03)00018-9","article-title":"Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients","volume":"37","author":"Zimmermann","year":"2003","journal-title":"J\u00a0Psychiatr Res"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395615001260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395615001260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T19:26:02Z","timestamp":1537644362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395615001260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":64,"alternative-id":["S0022395615001260"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2015.04.023","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced glycation end products and schizophrenia: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2015.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}